Brief: Armata Pharmaceuticals Announces Third Quarter 2022 Results
09/11/2022 21:18
Nov 9 (Reuters) - Armata Pharmaceuticals Inc ARMP.A :
* ARMATA PHARMACEUTICALS ANNOUNCES THIRD QUARTER 2022
RESULTS AND
PROVIDES CORPORATE UPDATE
* ARMATA PHARMACEUTICALS INC - QTRLY NET LOSS PER SHARE,
BASIC AND
DILUTED $0.24
Source text for Eikon: ID:nPn2HjMrFa
Further company coverage: ARMP.A
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Armata Pharmaceuticals
See all newsBrief: Armata Pharmaceuticals Announces First Quarter 2026 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Delays Announcement Of Fourth Quarter And Full-Year 2025 Results And Provides Corporate Update
Brief: Armata Pharmaceuticals Receives FDA Qualified Infectious Disease Product Designation
Armata Pharma jumps on US FDA nod for late-stage infection trial
Brief: Armata Pharmaceuticals Commissions cGMP Manufacturing Facility In Los Angeles